- DEI considerations: How can we establish trust within less-represented groups?
- How can patient advocacy groups remain at the forefront of the discussion on study design and tailored communication programs
- Overcoming obstacles in recruiting pediatric patients and how to make it easier for them and their parents to participate
- Ensuring optimal communication with sites to support their efforts
- The need for clinical trials to be accessible to patients
Chair: Ros Cheetham, Vice President, Clinical Operations, MacroGenics